Login / Signup

Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registry.

Elke LainkaMelanie BaehrBernadette RaszkaJohannes-Peter HaasBoris HügleNadine FischerDirk FoellClaas HinzeElisabeth Weissbarth-RiedelTilmann KallinichGerd HorneffDaniel WindschallEggert LilienthalTim NiehuesUlrich NeudorfRainer BerendesRolf-Michael KüsterPrasad Thomas OommenChristoph RietschelThomas LutzFrank Weller-HeinemannKlaus TenbrockGeorg Leonhard HeubnerJens KlotscheHelmut Wittkowski
Published in: Pediatric rheumatology online journal (2021)
In a large cohort of sJIA patients from Germany, we can confirm an overall favorable clinical response to both available IL-1 blocking agents. IL-1i was well tolerated with acceptable safety and effectiveness in a real-life clinical setting.
Keyphrases
  • juvenile idiopathic arthritis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • randomized controlled trial
  • systematic review
  • peritoneal dialysis
  • electronic health record
  • patient reported
  • drug induced